Durable control of small cell carcinoma of the urinary bladder by gemcitabine and paclitaxel

International Journal of Urology

Volumn 9, Issue 2, 2002, Pages 122-124

  Matsui, Yoshiyuki ^a   Fujikawa, Keita ^a   Iwamura, Hiroshi ^a   Oka, Hiroya ^a   Fukuzawa, Shigeki ^a   Takeuchi, Hideo ^a  

^a KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

Bladder; Gemcitabine; Paclitaxel; Small cell carcinoma

Indexed keywords

GEMCITABINE; PACLITAXEL;

ADULT; ARTICLE; BLADDER CARCINOMA; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER RECURRENCE; CASE REPORT; CYSTOSCOPY; DRUG EFFICACY; ENZYME BLOOD LEVEL; HUMAN; LUNG CANCER; LYMPH NODE METASTASIS; MALE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SMALL CELL CARCINOMA; TREATMENT OUTCOME;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; DEOXYCYTIDINE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; URINARY BLADDER NEOPLASMS;

EID: 0036222198     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2002.00434.x     Document Type: Article

References (3)

1. Small cell carcinoma of the urinary bladder treated with chemotherapy and radiotherapy: Results in five cases
2. Bladder preservation and durable complete remission of small cell carcinoma of the bladder with systemic chemotherapy and adjuvant radiation therapy
3. Gemcitabine/paclitaxel-based three-drug regimens in advanced urethral cancer